Reset filters
  • 16 April 2016

Low-cost generic hepatitis C drugs match branded products in viral response

Read the article
Dr James Freeman presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 15 April 2016

Shifting hepatitis C treatment to primary care providers could expand availability

Read the article
Sarah Kattakuzhy of the University of Maryland presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 15 April 2016

Sofosbuvir/velpatasvir + GS-9857 works well for treatment-experienced hepatitis C patients

Read the article
Eric Lawitz of the Texas Liver Institute presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 14 April 2016

Hepatitis C treatment may not be enough to stop the progress of advanced liver disease, or reduce liver transplant need

Read the article
Dr Carlos Fernández Carrillo presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 13 April 2016

$300 hepatitis C combination to enter clinical trials

Read the article
  • 13 April 2016

People not taking HIV treatment feel under pressure to ‘do the right thing’

Read the article
  • 13 April 2016

Resistance to anti-HIV drugs in steep decline in Switzerland

Read the article
  • 12 April 2016

Primary care doctors and nurse practitioners can successfully treat people with hepatitis C

Read the article
  • 11 April 2016

A third of MSM with HIV/HCV co-infection have HCV in their semen

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.